Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Precision BioSciences has obtained US patent for methods used in genetically-modified cell production, leveraging genome editing tools.
Subscribe to our email newsletter
Precision’s next-generation genome engineering technologies, collectively known as the Directed Nuclease Editor or DNE, aids in making the tools and resulting cells possible.
Precision chief scientific officer and co-inventor Jeff Smith said, "This newly issued patent provides the company with broad claims to many of the methods used by DNE nucleases to modify eukaryotic cells."
Precision’s DNE technology enables accurate gene editing with engineered nucleases.